Biology of Blood and Marrow Transplantation
Volume 15, Issue 12 , Pages 1555-1562 , December 2009

A Phase III Study of Infliximab and Corticosteroids for the Initial Treatment of Acute Graft-versus-Host Disease

  • Daniel R. Couriel

      Affiliations

    • Sarah Cannon Blood and Marrow Transplantation Program, Tennessee Oncology/Sarah Cannon Research Institute, Nashville, Tennessee
    • Corresponding Author InformationCorrespondence and reprint requests: Daniel R Couriel, MD, 250 25th Avenue North, Suite 412, Nashville, TN 37212.
    • ,
  • Rima Saliba

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Marcos de Lima

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Sergio Giralt

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Borje Andersson

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Issa Khouri

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Chitra Hosing

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Cindy Ippoliti

      Affiliations

    • Department of Hematology/Oncology, New York Presbiterian Hospital, Cornell Medical Center, New York, New York
    • ,
  • Elizabeth J. Shpall

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Richard Champlin

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Amin Alousi

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Received 2 July 2009 ,Accepted 2 August 2009.

  • Image Result

    CI of survival for patients with aGVHD treated with MP or infliximab plus MP.

    CI of survival for patients with aGVHD treated with MP or infliximab plus MP.

  • Image Result

    CI of NRM for patients with aGVHD treated with MP or infliximab plus MP.

    CI of NRM for patients with aGVHD treated with MP or infliximab plus MP.

 Financial disclosure: See Acknowledgments on page 1561.

PII: S1083-8791(09)00365-6

doi: 10.1016/j.bbmt.2009.08.003

Biology of Blood and Marrow Transplantation
Volume 15, Issue 12 , Pages 1555-1562 , December 2009

Article Tools

* Image Usage & Resolution